RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Everardo Cobos to Xenograft Model Antitumor Assays

Back to Details
This is a "connection" page, showing publications Everardo Cobos has written about Xenograft Model Antitumor Assays.
Everardo Cobos
Connection Strength
0.078
Xenograft Model Antitumor Assays
  1. Mirandola L, Yu Y, Chui K, Jenkins MR, Cobos E, John CM, Chiriva-Internati M. Galectin-3C inhibits tumor growth and increases the anticancer activity of bortezomib in a murine model of human multiple myeloma. PLoS One. 2011; 6(7):e21811.
    View in: PubMed
    Score: 0.078
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support